Reig M - Search Results

1

Immune-mediated adverse events and overall survival with tremelimumab plus durvalumab and durvalumab monotherapy in unresectable HCC: HIMALAYA phase III randomized clinical trial.

Lau G, Sangro B, Cheng AL, Kudo M, Kelley RK, Tak WY, Gasbarrini A, Reig M, Lim HY, Tougeron D, De Toni EN, Tam VC, Mody K, Gong J, Crysler OV, Sukeepaisarnjaroen W, Lipatov O, Morimoto M, Archambeaud I, Burgio V, Phuong LTT, Chao Y, Peron JM, Berres ML, Ko YJ, Ran D, Makowsky M, Negro A, Abou-Alfa GK. Lau G, et al. Among authors: reig m. Hepatology. 2025 May 16. doi: 10.1097/HEP.0000000000001385. Online ahead of print. Hepatology. 2025. PMID: 40384092

2

Intrahepatic peripheral cholangiocarcinoma in cirrhosis patients may display a vascular pattern similar to hepatocellular carcinoma on contrast-enhanced ultrasound.

Vilana R, Forner A, Bianchi L, García-Criado A, Rimola J, de Lope CR, Reig M, Ayuso C, Brú C, Bruix J. Vilana R, et al. Among authors: reig m. Hepatology. 2010 Jun;51(6):2020-9. doi: 10.1002/hep.23600. Hepatology. 2010. PMID: 20512990

3

Clinical decision making and research in hepatocellular carcinoma: pivotal role of imaging techniques.

Bruix J, Reig M, Rimola J, Forner A, Burrel M, Vilana R, Ayuso C. Bruix J, et al. Among authors: reig m. Hepatology. 2011 Dec;54(6):2238-44. doi: 10.1002/hep.24670. Hepatology. 2011. PMID: 21932394 Review. No abstract available.

4

Survival of patients with hepatocellular carcinoma treated by transarterial chemoembolisation (TACE) using Drug Eluting Beads. Implications for clinical practice and trial design.

Burrel M, Reig M, Forner A, Barrufet M, de Lope CR, Tremosini S, Ayuso C, Llovet JM, Real MI, Bruix J. Burrel M, et al. Among authors: reig m. J Hepatol. 2012 Jun;56(6):1330-5. doi: 10.1016/j.jhep.2012.01.008. Epub 2012 Feb 5. J Hepatol. 2012. PMID: 22314428

5

Postprogression survival of patients with advanced hepatocellular carcinoma: rationale for second-line trial design.

Reig M, Rimola J, Torres F, Darnell A, Rodriguez-Lope C, Forner A, Llarch N, Ríos J, Ayuso C, Bruix J. Reig M, et al. Hepatology. 2013 Dec;58(6):2023-31. doi: 10.1002/hep.26586. Epub 2013 Oct 29. Hepatology. 2013. PMID: 23787822

6

Regorafenib as second-line therapy for intermediate or advanced hepatocellular carcinoma: multicentre, open-label, phase II safety study.

Bruix J, Tak WY, Gasbarrini A, Santoro A, Colombo M, Lim HY, Mazzaferro V, Wiest R, Reig M, Wagner A, Bolondi L. Bruix J, et al. Among authors: reig m. Eur J Cancer. 2013 Nov;49(16):3412-9. doi: 10.1016/j.ejca.2013.05.028. Epub 2013 Jun 25. Eur J Cancer. 2013. PMID: 23809766 Free article. Clinical Trial.

7

Sorafenib or placebo plus TACE with doxorubicin-eluting beads for intermediate stage HCC: The SPACE trial.

Lencioni R, Llovet JM, Han G, Tak WY, Yang J, Guglielmi A, Paik SW, Reig M, Kim DY, Chau GY, Luca A, Del Arbol LR, Leberre MA, Niu W, Nicholson K, Meinhardt G, Bruix J. Lencioni R, et al. Among authors: reig m. J Hepatol. 2016 May;64(5):1090-1098. doi: 10.1016/j.jhep.2016.01.012. Epub 2016 Jan 22. J Hepatol. 2016. PMID: 26809111 Clinical Trial.

8

Unexpected high rate of early tumor recurrence in patients with HCV-related HCC undergoing interferon-free therapy.

Reig M, Mariño Z, Perelló C, Iñarrairaegui M, Ribeiro A, Lens S, Díaz A, Vilana R, Darnell A, Varela M, Sangro B, Calleja JL, Forns X, Bruix J. Reig M, et al. J Hepatol. 2016 Oct;65(4):719-726. doi: 10.1016/j.jhep.2016.04.008. Epub 2016 Apr 13. J Hepatol. 2016. PMID: 27084592

9

Assessment of treatment efficacy in hepatocellular carcinoma: Response rate, delay in progression or none of them.

Bruix J, Reig M, Sangro B. Bruix J, et al. Among authors: reig m. J Hepatol. 2017 Jun;66(6):1114-1117. doi: 10.1016/j.jhep.2017.02.032. Epub 2017 Mar 9. J Hepatol. 2017. PMID: 28284917 No abstract available.

10

Complete response under sorafenib in patients with hepatocellular carcinoma: Relationship with dermatologic adverse events.

Rimola J, Díaz-González Á, Darnell A, Varela M, Pons F, Hernandez-Guerra M, Delgado M, Castroagudin J, Matilla A, Sangro B, Rodriguez de Lope C, Sala M, Gonzalez C, Huertas C, Minguez B, Ayuso C, Bruix J, Reig M. Rimola J, et al. Among authors: reig m. Hepatology. 2018 Feb;67(2):612-622. doi: 10.1002/hep.29515. Epub 2018 Jan 2. Hepatology. 2018. PMID: 28898447 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

257 results

Search Page

Filters